321 related articles for article (PubMed ID: 19148512)
1. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
Lee OJ; Kim HJ; Kim JR; Watanabe H
Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
[TBL] [Abstract][Full Text] [Related]
2. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
3. Unclassified mucin phenotype of gastric adenocarcinoma exhibits the highest invasiveness.
Han HS; Lee SY; Lee KY; Hong SN; Kim JH; Sung IK; Park HS; Jin CJ; Min YI
J Gastroenterol Hepatol; 2009 Apr; 24(4):658-66. PubMed ID: 19175827
[TBL] [Abstract][Full Text] [Related]
4. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
[TBL] [Abstract][Full Text] [Related]
5. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer.
Wakatsuki K; Yamada Y; Narikiyo M; Ueno M; Takayama T; Tamaki H; Miki K; Matsumoto S; Enomoto K; Yokotani T; Nakajima Y
J Surg Oncol; 2008 Aug; 98(2):124-9. PubMed ID: 18521835
[TBL] [Abstract][Full Text] [Related]
7. Malignant potential regarding mucin phenotypes and endocrine cell differentiation in gastric adenocarcinoma.
Naritomi K; Futami K; Arima S; Iwashita A
Anticancer Res; 2003; 23(6a):4411-22. PubMed ID: 14666728
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
[TBL] [Abstract][Full Text] [Related]
10. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma.
Nakamura T; Yao T; Kabashima A; Nishiyama K; Maehara Y; Tsuneyoshi M
Histopathology; 2005 Oct; 47(4):357-67. PubMed ID: 16178890
[TBL] [Abstract][Full Text] [Related]
11. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis.
Akyürek N; Akyol G; Dursun A; Yamaç D; Günel N
Pathol Res Pract; 2002; 198(10):665-74. PubMed ID: 12498221
[TBL] [Abstract][Full Text] [Related]
12. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas.
Gürbüz Y; Kahlke V; Klöppel G
Virchows Arch; 2002 May; 440(5):505-11. PubMed ID: 12021925
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
14. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
[TBL] [Abstract][Full Text] [Related]
15. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions.
Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
Oncology; 2001; 61(3):212-20. PubMed ID: 11574777
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of histologic classifications of advanced stomach cancer: comparative study of Lauren's and Goseki's classifications].
Guglielmi A; de Manzoni G; Tomezzoli A; Ricci F; Pelosi G; Laterza E; Di Leo A; Bonfiglio M
Chir Ital; 1997; 49(3):45-9. PubMed ID: 9612652
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of gastric and intestinal mucin phenotypes of gastric carcinoma.
Mabuchi N; Niwa Y; Hirooka Y; Ohmiya N; Itoh A; Maeda O; Ando T; Goto H
Hepatogastroenterology; 2008; 55(88):2277-81. PubMed ID: 19260522
[TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype.
Motoshita J; Nakayama H; Taniyama K; Matsusaki K; Yasui W
Pathol Int; 2006 Apr; 56(4):200-5. PubMed ID: 16634965
[TBL] [Abstract][Full Text] [Related]
19. The clinical meaning of mucin phenotype and Epstein-Barr virus infection in gastric cancer.
Nakamura Y; Yanai H; Kitoh T; Matsubara Y; Hirano A; Okamoto T; Yoshida T; Nishikawa J; Okita K
Hepatogastroenterology; 2008; 55(81):41-5. PubMed ID: 18507075
[TBL] [Abstract][Full Text] [Related]
20. Mucin expression in gastric cancer: reappraisal of its clinicopathologic and prognostic significance.
Kim DH; Shin N; Kim GH; Song GA; Jeon TY; Kim DH; Lauwers GY; Park DY
Arch Pathol Lab Med; 2013 Aug; 137(8):1047-53. PubMed ID: 23899060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
